Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
4th Jun 20264:56 pmRNSNet Asset Value(s)
1st Jun 20265:03 pmRNSNet Asset Value(s)
26th May 20264:26 pmRNSNet Asset Value(s)
18th May 20265:17 pmRNSNet Asset Value(s)
11th May 20264:46 pmRNSNet Asset Value(s)
11th May 20267:53 amRNSNet Asset Value(s)
7th May 20267:00 amRNSWeekly Net Asset Value Reporting
21st Apr 202610:00 amRNSDirector/PDMR Shareholding
20th Apr 20269:43 amRNSDirector/PDMR Shareholding
16th Apr 20269:37 amRNSProposed acquisition of Animalcare Group Plc
13th Apr 20262:16 pmRNSDirector/PDMR Shareholding
13th Apr 20262:05 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:55 pmRNSDirector/PDMR Shareholding
10th Apr 20264:48 pmRNSNet Asset Value(s)
27th Mar 20267:00 amRNSAppointment of new Chairman
23rd Mar 202610:29 amRNSPassing of the Chairman
9th Mar 202611:19 amRNSNet Asset Value(s)
11th Feb 202610:37 amRNSEGM Requisition
9th Feb 20269:08 amRNSNet Asset Value(s)
3rd Feb 20261:46 pmRNSNet Asset Update
30th Jan 202610:02 amRNSPotential Bid for Pinewood Technologies Group Plc
22nd Jan 20269:40 amRNSBid for Kitwave Plc
9th Jan 20264:31 pmRNSNet Asset Value(s)
10th Dec 20257:00 amRNSHalf-year Financial Report
8th Dec 202510:55 amRNSNet Asset Value(s)
10th Nov 20253:40 pmRNSNet Asset Value(s)
9th Oct 20253:13 pmRNSNet Asset Value(s)
18th Sep 20251:47 pmRNSChange of Corporate Broker
9th Sep 20257:00 amRNSInvestor Presentation
8th Sep 202511:15 amRNSNet Asset Value(s)
20th Aug 202511:03 amRNSResult of AGM
8th Aug 202512:22 pmRNSNet Asset Value(s)
23rd Jul 20254:13 pmRNSNotice of AGM
10th Jul 202512:06 pmRNSDirector/PDMR Shareholding
9th Jul 20251:54 pmRNSNet Asset Value(s)
7th Jul 20257:00 amRNSAnnual Financial Report
10th Jun 202512:16 pmRNSNet Asset Value(s)
4th Jun 20254:18 pmRNSDirector/PDMR Shareholding
12th May 20251:12 pmRNSNet Asset Value(s)
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
8th Apr 20252:41 pmRNSNet Asset Value(s)
18th Mar 20259:22 amRNSDirector/PDMR Shareholding
10th Mar 20255:56 pmRNSNet Asset Value(s)
17th Feb 20253:45 pmRNSDirector/PDMR Shareholding
10th Feb 202511:35 amRNSNet Asset Value(s)
4th Feb 20253:07 pmRNSDirector/PDMR Shareholding
20th Jan 20254:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.